[1. Bassetti M, Righi E, Ansaldi F et al. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med. 2015;41(9):1601-1610.10.1007/s00134-015-3866-226077063]Search in Google Scholar
[2. Blot SI, Vandewoude KH, De Waele JJ. Candida peritonitis. Curr Opin Crit Care. 2007;13(2):195-199.10.1097/MCC.0b013e328028fd9217327742]Search in Google Scholar
[3. Montravers P, Mira JP, Gangneux JP et al. AmarCand study group. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive care units. Clin Microbiol Infect. 2011;17(7):1061-1067.10.1111/j.1469-0691.2010.03360.x20825438]Search in Google Scholar
[4. Sandven P, Qvist H, Skovlund E, Giercksky KE. NORGAS Group and the Norwegian Yeast Study Group. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med. 2002;30(3):541-547.10.1097/00003246-200203000-0000811990912]Search in Google Scholar
[5. Dupont H, Paugam-Burtz C, Muller-Serieys C et al. Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg. 2002;137(12):1341-1346; discussion 1347.10.1001/archsurg.137.12.134112470095]Search in Google Scholar
[6. Leroy O, Gangneux JP, Montravers P et al. AmarCand Study Group. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med. 2009;37(5):1612-1618.10.1097/CCM.0b013e31819efac019325476]Search in Google Scholar
[7. Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis: An Official Publication of the Infectious Diseases Society of America. 2016;62(4):e1-e50.10.1093/cid/civ933472538526679628]Search in Google Scholar
[8. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133-163.10.1128/CMR.00029-06179763717223626]Search in Google Scholar
[9. Playford EG, Marriott D, Nguyen Q et al. Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp. Crit Care Med. 2008;36(7):2034-2039.10.1097/CCM.0b013e3181760f4218552700]Search in Google Scholar
[10. Kollef M, Micek S, Hampton N et al. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis. 2012;54(12):1739-1746.10.1093/cid/cis30522423135]Search in Google Scholar
[11. Vergidis P, Clancy CJ, Shields RK et al. IntraAbdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment. PLoS One. 2016;11(4): e0153247.10.1371/journal.pone.0153247]Search in Google Scholar
[12. Blot S, De Waele JJ. Critical issues in the clinical management of complicated intra-abdominal infections. Drugs. 2005;65(12):1611-1620.10.2165/00003495-200565120-00002]Search in Google Scholar
[13. Islam S, Zaidi A, Wilson J. Peritoneal Infection with Multiple Species of Candida: A Case Report. Surgical Infections. 2002;3(1):35-37.10.1089/109629602753681140]Search in Google Scholar
[14. Schulze J, Sonnenborn U. Yeasts in the Gut: From Commensals to Infectious Agents. Dtsch Arztebl Int. 2009;106(51-52):837-842.]Search in Google Scholar
[15. Mathews HL, Witek-Janusek L. Host defense against oral, esophageal, and gastrointestinal candidiasis. In: Calderone RA (ed.): Candida and candidiasis. Washington: ASM Press 2002;179-192.]Search in Google Scholar
[16. De Ruiter J, Weel J, Manusama E et al. The epidemiology of intraabdominal flora in critically ill patients with secondary and tertiary abdominal sepsis. Infection. 2009;37:522-527.10.1007/s15010-009-8249-6]Search in Google Scholar
[17. Dupont H, Bourichon A, Paugam-Burtz C et al. Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med. 2003;31(3):752-757.10.1097/01.CCM.0000053525.49267.77]Search in Google Scholar
[18. Lee SC, Fung CP, Chen HY et al. Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B. Diagn Microbiol Infect Dis. 2002;44(1):23-27.10.1016/S0732-8893(02)00419-4]Search in Google Scholar
[19. Tortorano AM, Peman J, Bernhardt H et al. ECMM Working Group on Candidaemia. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis. 2004;23(4):317-322.10.1007/s10096-004-1103-y15029512]Search in Google Scholar
[20. Carneiro HA, Mavrakis A, Mylonakis E. Candida peritonitis: an update on the latest research and treatments. World J Surg. 2011;35(12):2650-2659.10.1007/s00268-011-1305-221976010]Search in Google Scholar
[21. Cornely OA, Bassetti M, Calandra T et al. ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: nonneutropenic adult patients. Clin Microbiol Infect. 2012;18 Suppl 7:19-37.10.1111/1469-0691.1203923137135]Search in Google Scholar
[22. Solomkin JS, Mazuski JE, Bradley JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(2):133-164.10.1086/64955420034345]Search in Google Scholar
[23. Alam FF, Mustafa AS, Khan ZU. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia. BMC Infect Dis. 2007;7:103.10.1186/1471-2334-7-103207551317784947]Search in Google Scholar
[24. Azuhata T, Kinoshita K, Kawano D et al. Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock. Crit Care. 2014;18(3):R87.10.1186/cc13854405711724886954]Search in Google Scholar
[25. Blot S, De Wele JJ, Vogelers D. Essentials for selecting antimicrobial therapy for intraabdominal infections. Drugs. 2012;72:e17-32.10.2165/11599800-000000000-00000358577022480338]Search in Google Scholar
[26. Parkins MD, Sabuda DM, Elsayed S, Laupland KB. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother. 2007;60(3):613-618.10.1093/jac/dkm21217576697]Search in Google Scholar